$11.59
1.07% yesterday
NYSE, Aug 25, 10:00 pm CET

Avanos Medical, Inc. Stock price

$11.60
-0.41 3.41% 1M
-3.96 25.45% 6M
-4.32 27.14% YTD
-12.07 50.99% 1Y
-15.46 57.13% 3Y
-20.56 63.93% 5Y
-17.82 60.57% 10Y
-29.40 71.71% 20Y
NYSE, Closing price Mon, Aug 25 2025
-0.11 0.94%

Key metrics

Basic
Market capitalization
$538.3m
Enterprise Value
$553.0m
Net debt
$14.7m
Cash
$90.3m
Shares outstanding
46.0m
Valuation (TTM | estimate)
P/E
negative | 14.3
P/S
0.8 | 0.8
EV/Sales
0.8 | 0.8
EV/FCF
6.3
P/B
0.7
Financial Health
Equity Ratio
71.8%
Return on Equity
-47.3%
ROCE
4.8%
ROIC
-
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$692.5m | $689.5m
EBITDA
$86.6m | $152.2m
EBIT
$43.6m | $128.9m
Net Income
$-463.1m | $37.4m
Free Cash Flow
$88.0m
Growth (TTM | estimate)
Revenue
1.5% | 0.3%
EBITDA
19.9% | 67.2%
EBIT
63.3% | 186.5%
Net Income
-6,114.3% | 109.5%
Free Cash Flow
109.5%
Margin (TTM | estimate)
Gross
53.8%
EBITDA
12.5% | 22.1%
EBIT
6.3%
Net
-66.9% | 5.4%
Free Cash Flow
12.7%
More
EPS
$-10.1
FCF per Share
$1.9
Short interest
5.8%
Employees
2k
Rev per Employee
$310.0k
Show more

Is Avanos Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Avanos Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Avanos Medical, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Avanos Medical, Inc. forecast:

Hold
50%
Sell
50%

Financial data from Avanos Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
693 693
1% 1%
100%
- Direct Costs 321 321
7% 7%
46%
373 373
2% 2%
54%
- Selling and Administrative Expenses 313 313
0% 0%
45%
- Research and Development Expense 24 24
8% 8%
3%
87 87
20% 20%
13%
- Depreciation and Amortization 43 43
5% 5%
6%
EBIT (Operating Income) EBIT 44 44
63% 63%
6%
Net Profit -463 -463
6,114% 6,114%
-67%

In millions USD.

Don't miss a Thing! We will send you all news about Avanos Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avanos Medical, Inc. Stock News

Neutral
Seeking Alpha
21 days ago
Avanos Medical, Inc. (NYSE:AVNS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M.
Neutral
The Motley Fool
21 days ago
Avanos Medical (AVNS) Q2 Revenue Up 2%
Neutral
PRNewsWire
21 days ago
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025.
More Avanos Medical, Inc. News

Company Profile

Avanos Medical, Inc. is a medical technology company, which focuses on delivering clinically medical device solutions to improve patients' quality of life. Its portfolio of innovative product offerings focused on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

Head office United States
CEO David Pacitti
Employees 2,227
Founded 2014
Website avanos.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today